RETRACTED: Oxymatrine Synergistically Potentiates the Antitumor Effects of Cisplatin in Human Gastric Cancer Cells (Retracted article. See vol. 12, pg. 3529, 2021)

被引:8
作者
Liu, Yan [1 ,2 ]
Qin, Lei [2 ]
Bi, Tingting [1 ]
Dai, Wei [1 ]
Liu, Wei [1 ]
Gao, Quangen [1 ]
Shen, Genhai [1 ]
机构
[1] Nantong Univ, Wujiang Peoples Hosp 1, Dept Gen Surg, Suzhou 215200, Jiangsu, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Dept Gen Surg, Hepatobiliary Surg, Suzhou 215200, Jiangsu, Peoples R China
关键词
Oxymatrine; Gastric cancer; Cisplatin; Synergistically; Reactive oxygen species; APOPTOSIS; INHIBITOR; PATHWAY; 5-FLUOROURACIL; CHEMOTHERAPY; COMBINATION; MECHANISMS; CARCINOMA; CYCLE;
D O I
10.7150/jca.28532
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cisplatin (CDDP) has been extensively used for gastric cancer (GC) treatment but limited by drug resistance and severe toxicity. The chemo-sensitizers that enhance its efficiency and overcome its limitation are urgently needed. Oxymatrine (OMT), a primary active ingredient from the dry roots of Sophora favescens, has shown powerful anti-cancer property with little side-effect. In this study, we explored the chemo-sensitization of OMT to potentiate the anti-tumor effect of CDDP. GC cell lines were dealt with OMT and/or CDDP and then subjected to different experimental methods. We found that OMT could significantly potentiate the CDDP-caused BGC-823 and SGC7901 cells viability loss, and OMT acts synergistically with CDDP. The combinative treatment could arrest cell cycle in G0/G1 phase by increasing p21, p27 and decreasing cyclin D1, and induced apoptosis by ROS generation and AKT/ERK inactivation. Inhibition of ROS respectively reversed the cell death induced by OMT and/or CDDP, suggesting the pivotal roles of ROS in the process. Moreover, OMT enhanced the antitumor effects of CDDP in nude mice bearing BGC823 tumor xenografts in vivo. Taken together, this study highlights that the co-treatment with OMT and CDDP exerted synergistic antitumor effects in GC cells, and that these effects may be mediated by ROS generation and inactivation of the AKT/ERK pathways.
引用
收藏
页码:4527 / 4535
页数:9
相关论文
共 50 条
[41]   RETRACTED: Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers (Retracted article. See vol. 18, pg. 1107, 2023) [J].
Yu, Guo ;
Ali, Zakir ;
Khan, Anam Sajjad ;
Ullah, Kalim ;
Jamshaid, Humzah ;
Zeb, Alam ;
Imran, Muhammad ;
Sarwar, Sadia ;
Choi, Han-Gon ;
Din, Fakhar Ud .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 :3255-3273
[42]   RETRACTED: Effect and mechanism of propofol in hepatic ischemia/reperfusion injury of rat (Retracted article. See vol. 25, pg. 4185, 2021) [J].
Wei, L. ;
Chen, W. -Y. ;
Hu, T. ;
Tang, Y. -X. ;
Pan, B. -B. ;
Jin, M. ;
Kong, G. -Y. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (15) :3516-3522
[43]   RETRACTED: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques (Retracted article. See vol. 203, pg. 1045, 2021) [J].
Foreman, Taylor W. ;
Bucsan, Allison N. ;
Mehra, Smriti ;
Peloquin, Charles ;
Doyle, Lara A. ;
Russell-Lodrigue, Kasi ;
Gandhi, Neel R. ;
Altman, John ;
Day, Cheryl L. ;
Ernst, Joel D. ;
Blumberg, Henry M. ;
Rengarajan, Jyothi ;
Kaushal, Deepak .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (04) :469-477
[44]   RETRACTED: EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression (Retracted article. See vol. 16, pg. 673, 2023) [J].
Wang, Chenyu ;
Li, Xingwang ;
Zhang, Junjie ;
Ge, Zheng ;
Chen, Hejin ;
Hu, Junhong .
ONCOTARGETS AND THERAPY, 2018, 11 :7853-7864
[45]   RETRACTED: Effect of CLIC1 gene silencing on proliferation, migration, invasion and apoptosis of human gallbladder cancer cells (Retracted article. See vol. 25, pg. 4522, 2021) [J].
He, Yue-Ming ;
Zhang, Zhong-Lin ;
Liu, Quan-Yan ;
Xiao, Yu-Sha ;
Wei, Lei ;
Xi, Chen ;
Nan, Xiang .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (05) :2569-2579
[46]   RETRACTED: Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5 (Retracted article. See vol. 236, pg. 8267, 2021) [J].
Sun, Yan ;
Sun, Hai .
JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (03) :2963-2972
[47]   RETRACTED: Direct renin inhibition: clinical pharmacology (Retracted article. See vol. 90, pg. 465, 2012) [J].
Azizi, Michel .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (06) :647-654
[48]   RETRACTED: Myostatin is a novel tumoral factor that induces cancer cachexia (Retracted article. See vol. 473, pg. 1111, 2016) [J].
Lokireddy, Sudarsanareddy ;
Wijesoma, Isuru Wijerupage ;
Bonala, Sabeera ;
Wei, Meng ;
Sze, Siu Kwan ;
McFarlane, Craig ;
Kambadur, Ravi ;
Sharma, Mridula .
BIOCHEMICAL JOURNAL, 2012, 446 :23-36
[49]   RETRACTED: Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo (Retracted article. See vol. 17, pg. 6927, 2018) [J].
Zhang, Xianqing ;
Hu, Xingbin ;
Mu, Shijie ;
Zhan, Yonghua ;
An, Qunxing ;
Liu, Zhixin ;
Huang, Xiaofeng .
MOLECULAR MEDICINE REPORTS, 2014, 10 (03) :1184-1194
[50]   RETRACTED: Potentiation of Mitomycin C Tumoricidal Activity for Transitional Cell Carcinoma by Histone Deacetylase Inhibitors In Vitro (Retracted article. See vol. 206, pg. 790, 2021) [J].
Deb, Abdalla Ali ;
Wilson, Shandra S. ;
Rove, Kyle O. ;
Kumar, Binod ;
Koul, Sweaty ;
Lim, Douglas D. ;
Meacham, Randall B. ;
Koul, Hari K. .
JOURNAL OF UROLOGY, 2011, 186 (06) :2426-2433